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Abstract
Background: Purification of polypeptides and proteins derived
from recombinant DNA techniques and of long synthetic
polypeptides often represents a challenge. Affinity methods exist,
but generally require addition of a large recognition unit to the
target protein and use of expensive purification media. Use of
large units is dictated by the characteristics of non-covalent
complexes, where the energy necessary to form the complex
derives from the sum of multiple weak energy interactions.
Covalent interactions in contrast are of high energy, even when
only a few bonds are formed. We decided to explore the use of the
reversible covalent bond formed between N-terminal cysteine and
threonine residues with an aldehyde as a method of protein
purification.
Results : A series of test peptides with N-terminal cysteine and
threonine were captured by a polyethyleneglycol^polyacrylamide
resin to which an aldehyde function had been grafted. Peptides
with other amino acids at the N-terminus did not interact with the
resin. A recombinant polypeptide with N-terminal cysteine was
purified to 90% purity in one step. Polypeptides were eluted from
the resin simply by adding a hydroxylamine derivative, which
reacts with aldehyde functions to form an oxime.
Conclusions: Polypeptides possessing N-terminal cysteine or
threonine can be easily purified using this ‘covalent capture’
approach. ß 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Covalent capture; Polypeptide puri¢cation; Recombinant pro-
tein puri¢cation
1. Introduction
Many methods exist for the a⁄nity puri¢cation of
proteins, but none is ideal [1]. For proteins produced by
recombinant DNA techniques, some methods rely on the
use of relatively inexpensive puri¢cation media, but in
contrast require fusion of the target protein with binding
domains (maltose binding protein, chitin binding domain,
thioredoxin, cellulose binding domain, glutathione
S-transferase or polyhistidine tag), which are large
enough, or peculiar enough, to possibly a¡ect function.
While these domains may sometimes be removed by enzy-
matic techniques, yields are often low due to low accessi-
bility of the cleavage site, and such cleavage can be ex-
pensive to perform on a large scale. Other approaches rely
on fusion with a small peptide tag, such as S-peptide and
the Flag peptide [1], but require expensive antibody-based
puri¢cation media. For polypeptides produced by chemi-
cal techniques (solid phase peptide synthesis), N-terminal
tags in combination with capping at every coupling step
have been explored with good results either for a⁄nity-
type puri¢cation or to modify the chromatographic prop-
erties of the correct peptide [2^5]. Unfortunately the harsh
conditions required for tag removal (cyanogen bromide,
20% piperidine and pH 12) limited their use.
We decided to exploit as a puri¢cation strategy a well-
known organic chemistry reaction, the formation of a ¢ve-
membered heterocyclic ring arising from the condensation
of a carbonyl group with a molecule carrying two vicinal
nucleophilic groups (^NH2, ^OH, ^SH) [6]. Two natural
amino acid residues, cysteine and threonine, when in the
N-terminal position, can undergo this reaction in an aque-
ous or semi-organic environment [7^9] while the same ami-
no acids elsewhere in a peptide sequence are completely
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unreactive due to the low nucleophilicity of the amide
nitrogen (Fig. 1). Curiously, N-terminal serine reacts
poorly with aldehyde groups, even in the presence of or-
ganic solvents. Our approach was to use a solid support
(resin) to which aldehyde groups were attached. A peptide
possessing an N-terminal cysteine (or threonine) reacts
with the resin while impurities and by-products such as
acetylated truncated peptides do not react. The ring for-
mation reaction proceeds to an equilibrium, which is
strongly in favor of product formation in the range pH
4.5^8, and permits extensive washes. This equilibrium can
be perturbed by introducing a competitor for the aldehyde
group, such as an aminoxy group, that rapidly reacts to
form an oxime, conveniently releasing the captured pep-
tide or protein (Fig. 1).
To demonstrate the applicability of the covalent capture
approach to the puri¢cation of synthetic and recombinant
DNA-derived polypeptides, we used sequences from the
chemokine Rantes. Certain derivatives of Rantes, modi¢ed
at the N-terminus, are useful in inhibiting entry of HIV-I
into macrophages, but require the chemical synthesis of
these modi¢ed proteins. Production by recombinant tech-
niques, and puri¢cation by covalent capture of a large
fragment of Rantes compatible with native chemical liga-
tion, could simplify the production of these anti-HIV
drugs [10,11].
2. Results
2.1. Capture of short peptides with N-terminal cysteine and
threonine
We began with a series of synthetic peptides with at the
N-terminal position: cysteine (CYAKYAKL, referred to
as Cyak); threonine (TYAKYAKL, referred to as Tyak);
serine (SYAKYAKL, referred to as Syak), and as a neg-
ative control tyrosine (YAKYAKL, referred to as yak).
Since peptides after synthesis are often solubilized in a
mixture of water/acetonitrile, we chose a solid support
(resin) compatible with these solvents in the form of the
commercially available amino PEGA resin from Novabio-
chem. This resin, prepared from polymerization of bis-
acrylamido polyethyleneglycol, monoacrylamido polyeth-
yleneglycol and N,N-dimethyl acrylamide, presents good
swelling properties in both aqueous and organic media
[12]. The amino groups on the resin were derivatized
with an aldehyde group. This aldehyde resin captured
Cyak quantitatively in a mixture of water and acetonitrile
either at pH 6.4 (Fig. 2) or at pH 4.5, simply upon incu-
bation of the peptide solution with the resin under gentle
agitation. At pH 6.4 capture was complete within 4 h
using two equivalents of aldehyde per equivalent of pep-
tide. Capture rate was a function of the resin quantity and
the peptide concentration, as expected for a bi-molecular
reaction, and working with a larger excess of resin (¢ve
equivalents) the reaction was completed in 1 h. Tyak was
less reactive, and 80% of the peptide was captured in 12 h
at pH 6.4 (Fig. 2), while only 5% was captured in the same
time at pH 4.5. The peptide Syak failed to react with the
resin and so did the control peptide yak, which lacks an
appropriate reactive amino acid at the N-terminus. In the
case of Cyak, the presence of a reducing or chelating agent
(dithiothreitol (DTT), Tris(2-carboxyethyl) phosphine
(TCEP) or EDTA, 10 mM) in the capture bu¡er increased
the yield of capture since it prevented the formation of
disul¢de dimer, which cannot react with aldehyde resin.
Care should be taken when employing DTT since an ex-
cess of this reagent might block the aldehyde binding sites,
a problem that we did not encounter using TCEP. Once
trapped on the resin the Cyak peptide was not released by
Fig. 1. Covalent capture concept. A peptide with an N-terminal cysteine
(or threonine, not shown) reacts with a resin possessing an aldehyde
function, forming a ¢ve-membered heterocyclic ring. Peptides lacking
this amino acid in the N-terminal position, or with an acetylated N-ter-
minus, do not react with the resin. Cysteines at intermediate positions
are not reactive. Once the correct sequence is covalently linked to the
resin, impurities and by-products are removed by ¢ltration and the resin
extensively washed with the same bu¡er. The puri¢ed peptide is eluted
with a solution of O-methylhydroxylamine, and recovered by ¢ltration.
CHBIOL 109 5-7-01
674 Chemistry & Biology 8/7 (2001) 673^679
repetitive washes with the capture bu¡er. Tyak binding
was less stable, but could still sustain repetitive washes
without great loss. Bound Cyak and Tyak were recovered
quantitatively from the resin by treating the resin with a
solution of O-methylhydroxylamine at pH 3 (Fig. 2) for
6 h. This is the optimal pH for release, but full release
could be obtained at higher pH (4.5) by extending the
elution time.
2.2. Selectivity of the aldehyde resin
To investigate the in£uence of peptide size on the cap-
ture process, and to check the selectivity of the resin for
N-terminal cysteine peptides, we used a synthetic 32-mer
peptide possessing N-terminal cysteine (pep1). The same
sequence was extended in the N-terminal direction with an
alanine residue (pep2) to check the reactivity of cysteine
when not in the N-terminal position. Using the same con-
ditions as for Cyak (pH 6.4), pep1 and pep2 were mixed
(Fig. 3a) and incubated with the aldehyde resin. Pep1 was
completely captured in 4 h, while pep2 failed to react with
the resin (Fig. 3b). After the washing steps, puri¢ed pep1
was eluted from the resin (Fig. 3c). The degree of puri¢-
cation achieved by this simple procedure is considerable.
2.3. Synthesis and puri¢cation of Rantes 34^68 from
truncated sequences
To investigate the applicability of covalent capture to
the case of a more di⁄cult synthetic peptide puri¢cation,
we synthesized by solid phase peptide synthesis (SPPS) a
35-mer peptide, Rantes 34^68 (fragment containing the
C-terminal 35 residues of the human chemokine Rantes),
using capping at every step before Boc removal. This pep-
tide possesses an N-terminal cysteine as well as cysteine
and threonine residues in internal positions. In order to
evaluate further the speci¢city of our covalent capture
puri¢cation method, at di¡erent steps of the synthesis a
portion of the resin was manually capped with acetic an-
hydride or with pyroglutamic acid (a common side reac-
tion of glutamine residues). These N-acylated fragments
were mixed with Rantes 34^68 and mixed with the alde-
hyde resin (Fig. 4a). Only Rantes 34^68 was captured,
while the di¡erent truncated peptides were not retained
(Fig. 4b). The eluted material contained mainly Rantes
34^68 (Fig. 4c). The small impurities present were identi-
¢ed by mass spectrometry as the Met68 oxidized product
and as p-cresol adducts (Fig. 4c). The degree of puri¢ca-
tion achieved (Fig. 4c vs. a) is considerable.
Further experiments were performed with synthetic pep-
Fig. 2. Analytical RP-HPLC of the supernatant at di¡erent stages of
Cyak and Tyak capture, using a gradient of 3%/min of solvent B. Vol-
umes injected were kept constant. (a) Initial conditions prior to capture
of Cyak; (b) 4 h capture of Cyak; (c) 6 h elution with O-methylhydrox-
ylamine hydrochloride; (d) initial conditions prior to capture of Tyak;
(e) 12 h capture of Tyak; (f) 6 h elution with O-methylhydroxylamine
hydrochloride. All the materials were analyzed by mass spectroscopy,
and the eluted material did not show any sign of modi¢cation.
Fig. 3. Analytical RP-HPLC of the supernatant of mixed pep1 and
pep2, using a gradient of 0.8%/min of solvent B. Volumes injected were
kept constant. (a) Initial conditions prior to capture; (b) 4 h capture;
(c) 6 h elution with O-methylhydroxylamine hydrochloride.
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tides possessing N-terminal Cys (Rantes 50^68 and Rantes
10^68), and Thr (Rantes 30^68). These experiments dem-
onstrated that all N-terminal cysteine fragments were
quantitatively captured by the resin. With increasing
length, peptide capture became slower, but in all cases it
was complete within 4 h at pH 6.4. The N-terminal threo-
nine peptide was captured in approximately 80% yield in
12 h. Interaction with the resin was not a¡ected by repet-
itive washes, and no peptide was detected in the bu¡er
used for washing steps. Elution with O-methylhydroxyl-
amine was quantitative and was achieved within 8 h. All
the eluted fragments possessed the expected mass spectrum
(data not shown).
2.4. Development of a capture resin for recombinant
polypeptides
To investigate the applicability of the covalent capture
approach to a polypeptide obtained through recombinant
DNA technology we developed a di¡erent type of alde-
hyde resin. This resin is based on a cross-linked dextran
support, compatible with solutions containing 6 M guani-
dinium chloride used when handling inclusion bodies pro-
duced by recombinant techniques. Rantes 10^68, a frag-
ment of wild-type Rantes possessing cysteine at the
N-terminus, was expressed in Escherichia coli using stan-
dard recombinant techniques with an initiating methionine
residue. We expected that the translation machinery of the
cell would remove the initiator methionine to liberate the
N-terminal cysteine. The inclusion bodies were collected
by centrifugation after cell lysis, solubilized directly in a
bu¡er containing 6 M guanidinium chloride and loaded
onto the dextran-based aldehyde resin with gentle agita-
tion overnight at 4‡C. Reverse-phase high performance
liquid chromatography (RP-HPLC) and mass spectrosco-
py analysis of the crude material indicated the presence of:
the desired Rantes 10^68 (about 30% of the total materi-
al) ; a protein corresponding to Met-Rantes 10^68 (+132
amu, expected +131); oxidized Met-Rantes 10^68 (+147
amu, expected +147), and doubly oxidized Met-Rantes
10^68 material (+163 amu, expected +163) (Fig. 5a). After
capture, the resin was washed extensively and the captured
material eluted with O-methylhydroxylamine. Neither
Met-Rantes 10^68 nor the oxidized materials were re-
tained by the resin. From 1 liter of induction medium of
Rantes 10^68, 0.5 mg of material with a purity of over
90% (Fig. 5c) was recovered, and this was ready for fur-
ther use after a desalting step.
Fig. 4. Analytical RP-HPLC of the supernatant of mixed acylated frag-
ments of Rantes 34^68, and correct Rantes 34^68 capture, using a gra-
dient of 0.8%/min of solvent B. Volumes injected were kept constant.
(a) Initial condition prior to capture; (b) 4 h capture; (c) 8 h elution
with O-methylhydroxylamine hydrochloride.
Fig. 5. Analytical RP-HPLC of the supernatant of crude recombinant
Rantes 10^68, using a gradient of 1%/min of solvent B. Volumes in-
jected were kept constant. (a) Initial condition prior to capture; (b) 4 h
capture; (c) 8 h elution with O-methylhydroxylamine hydrochloride.
CHBIOL 109 5-7-01
676 Chemistry & Biology 8/7 (2001) 673^679
3. Discussion
The results reported here clearly demonstrate that it is
possible to use the reversible covalent reaction of thiazo-
lidine or oxazolidine formation as a basis for polypeptide
puri¢cation. The advantages of such a puri¢cation ap-
proach are multiple. First is the use of inexpensive puri¢-
cation media, available with high capacity (50 mM or
greater), stable for many months and compatible with
the conditions employed after peptide synthesis and after
protein production by recombinant techniques. These me-
dia can be simply added to the solution containing the
protein or polypeptide, and the capture reaction per-
formed in batch mode, without a chromatographic step.
Washes can be performed similarly, since the stability of a
covalent interaction eliminates di¡usion problems. Elution
is achieved with a compound that reacts speci¢cally with
the resin, again in batch mode. Since no chromatographic
step is involved, the protein can be eluted in a minimal
volume, and isolated from the resin by simple ¢ltration.
Second, use of a natural amino acid as the capture tag
allows this technique to be adopted in the case of recombi-
nant proteins. If the target protein happens to possess a
cysteine or threonine at the N-terminus, no further elabo-
ration of the sequence is necessary. If not, di¡erent op-
tions are possible. Extension or substitution of the natural
sequence with a threonine or a cysteine capture tag would
probably not a¡ect the biological activity of the target
protein and is the simplest solution. Threonine seems the
better option, since it avoids the problem of incorrect di-
sul¢de bridge formation. Alternatively, an enzymatically
cleavable sequence could follow the terminal cysteine or
threonine, and be removed after the puri¢cation, but adds
expense and complexity. The results demonstrated are en-
couraging but of course the size limit of recombinant-de-
rived polypeptides and proteins which may be puri¢ed by
covalent capture remains to be determined, and larger
proteins may require a Sepharose-based matrix rather
than the PEGA and Sephadex matrices used here.
Third, if a cysteine or threonine capture tag is employed
in SPPS in conjunction with a capping step after every
amino acid coupling, it will allow the selective recovery
of the correct sequence from among the multiple incom-
plete sequences produced, creating a simpler semi-puri¢ed
product for ¢nal HPLC puri¢cation. A fourth important
advantage in using cysteine as a capture tag lies in the
increasing use of native chemical ligation (NCL) [13,14].
Since the introduction of NCL and expressed protein liga-
tion [15], the number of applications of peptides and pro-
teins with N-terminal cysteine has increased exponentially.
NCL is used to join two or more protein or peptide frag-
ments by transthioesterifying an N-terminal cysteine thiol
in one fragment with a C-terminal thioester in the other
fragment. The unstable thioester bond ¢rst formed then
rearranges by an SCN acyl shift and yields a natural
amide bond. For NCL, the process requires use of fairly
pure peptides, limiting the length of precursor fragments
employed in each ligation step to 30^35 residues. With our
puri¢cation technique we believe it will be possible to ex-
tend the length of a peptide precursor beyond the 59-res-
idue recombinant example shown here, expanding enor-
mously the number of proteins accessible to NCL.
Finally, an N-terminal cysteine represents an optimal
selective reactive group for the introduction of any type
of reporter tag carrying an aldehydic or ketonic function
[7]. This would be of enormous advantage in protein ex-
pression, since such a polypeptide product contains both
the puri¢cation tag and the derivatization tag, thus sim-
plifying biochemical applications. By inserting a linker
which is removable (chemically or enzymatically) under
mild conditions, between a cysteine or threonine capture
unit and the target protein the covalent capture approach
becomes generally applicable.
4. Signi¢cance
After a protein or polypeptide has been produced, by
chemical or recombinant DNA means, it is necessary to
purify it. Quite often, the crude sample contains some
protein or polypeptide species which are quite close in
structure and properties to the wanted product and puri-
¢cation can be a lengthy and expensive process with some-
times low yields. We describe a rapid, simple and high-
yield one-step puri¢cation process which is based on
chemical rather than physical properties. The technique
is particularly suited for the puri¢cation of polypeptides
used in fragment condensations such as NCL or expressed
chemical ligation. By eliminating bulk impurities in a sim-
ple step, covalent capture facilitates ¢nal puri¢cation at a
smaller scale by complementary techniques.
5. Materials and methods
5.1. Peptide synthesis
All peptides were prepared by SPPS using machine-as-
sisted protocols on a custom-modi¢ed Applied Biosystems
model 430A peptide synthesizer using the in situ neutralization/
2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexa£uoro-
phosphate activation procedure for Boc chemistry as described
[16]. Peptide identity was con¢rmed by MALDI-TOF spectrosco-
py on a Voyager Elite or STR DE machine (PE Biosystems,
Foster City, CA, USA).
The short peptide sequences used were: Cyak, CYAKYAKL;
Tyak, TYAKYAKL; Syak, SYAKYAKL; and yak, YAKYA-
KL. These peptides were puri¢ed by preparative RP-HPLC.
The longer peptides were used directly as crude material : Pep1
was CAVVFVTRKNRQVSANPEKKAVREYINSLELA and
Pep2 ACAVVFVTRKNRQVSANPEKKAVREYINSLELA.
Rantes 34^68 was CSNPAVVFVTRKNRQVCANPEKKWV-
CHBIOL 109 5-7-01
Research Paper Covalent capture as puri¢cation tool M. Villain et al. 677
REYINSLEMS, while the truncated fragments of Rantes 34^68
were Ac-39^68, Ac-VVFVTRKNRQVCANPEKKWVREYINS-
LEMS; Ac-44^68, Ac-RKNRQVCANPEKKWVREYINSL-
EMS; and pGlu-49^68, pGlu-VCANPEKKWVREYINSLEMS.
5.2. Capture resin preparation
The polyethyleneglycol^polystyrene (PEG)-based aldehyde res-
in was prepared starting from Amino PEGA resin (Novabio-
chem, Laufel¢ngen, Switzerland) with a nominal free amine sub-
stitution of 0.05 mmol/g of wet resin. The resin was rinsed with
dimethylformamide (DMF), then treated with succinic anhydride/
N-hydroxybenzotriazole/diisopropylethylamine (10/10/10 equiva-
lents calculated over the amine substitution) in DMF overnight.
Excess reagents were removed by ¢ltration and the resin washed
with DMF. The same washing procedure was applied to all the
following steps. The carboxylic resin thus obtained was activated
with 40 eq. of 1,1P-carbonyl-diimidazole in DMF for 1 h, washed,
and functionalized with 30 eq. of 2-amino-acetaldehyde diethyl
acetal in the presence of 20 eq. of N-hydroxybenzotriazole. The
aldehyde function was liberated from the acetal by treating the
resin with tri£uoroacetic acid (TFA)/H2O (1:1) for 1 h and rins-
ing with H2O/acetonitrile (1:1). Aldehyde resin substitution was
evaluated using a £uorescence method based on the dye dansyl-
hydrazine [17]. The evaluation was conducted on the resin
washed with dichloromethane and dried under vacuum overnight.
The total amount of dansylhydrazine found bound to the resin
was corrected by subtracting the amount of dye molecules asso-
ciated non-covalently with the same amount of amino PEGA
resin capped with acetic anhydride. We calculated an aldehyde
substitution of 0.4 mmol/g of dry resin. This value is consistent
with the expected value (0.4 mmol/g of dry resin) considering the
orginal resin substitution reported by the producer (0.05 mmol/g
of wet resin). We measured a loss of weight after the drying
procedure of 7 parts in 8, so the wet resin used possessed a
nominal aldehyde substitution of 0.05 mmol/g. The resin was
stored at 4‡C as a slurry in H2O/acetonitrile for up to 5 months.
The dextran support was prepared starting from Sephadex CM
C50 (Pharmacia, Uppsala, Sweden), with a nominal carboxylic
acid substitution of 4.5 mmol/g of dry resin. The resin was swol-
len according to the manufacturer’s instructions, and equilibrated
with 200 mM sodium phosphate bu¡er, pH 6.5. The carboxylic
function was activated with a water solution of N-hydroxysucci-
nimide and 1P-ethyl-(3P-dimethylaminopropyl)-carbodiimideWHCl
(2 eq. and 4 eq. respectively over the carboxylic groups) for
8 min. The resin was rapidly rinsed with H2O and incubated
for 1 h with a water solution of 2-amino-acetaldehyde diethyl
acetal (1 M) and 200 mM 2-morpholino-ethanesulfonic acid
(MES) adjusted to pH 6.4 with HCl. After 1 h the aldehyde
precursor was eliminated, any unreacted sites were blocked by
incubation with a solution of ammonium acetate 1 M pH 7.5
for 10 min, and the resin rinsed thoroughly with 10 mM HCl
to liberate the aldehyde function. The resulting aldehyde resin
was equilibrated with 0.1 M acetic acid prior to storage at 4‡C.
It was active for up to 5 months.
5.3. Cloning and expression of Rantes 10^68
Met-Rantes 10^68, MCCFAYIARPLPRAHIKEYFYTSGK-
CSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS, was
made from single-strand phage DNA encoding the full-length
native molecule. The truncated gene was created using classical
PCR techniques and inserted into the expression vector pET-22b.
Plasmid production was obtained using E. coli XL1-blu strain.
The puri¢ed plasmid was introduced into E. coli BL21 strain.
Cells were grown on 5 l of LB medium [18] and induced for 4 h
at 37‡C with 1 mM IPTG. After centrifugation, cells were pro-
cessed with lysis bu¡er, sonicated and washed with 2 M urea/
5 mM DTT. The inclusion body fraction was collected by high
speed centrifugation.
5.4. Covalent capture protocol
In a typical capture experiment on the PEG resin, peptides
were dissolved in a solution of H2O/acetonitrile 1:1 containing
either 0.1 M MES at pH 6.4 or 0.1 M sodium acetate at pH 4.5.
For peptides containing cysteine, 10 mM TCEP was used to limit
disul¢de bond formation. Peptides were used at a concentration
of 1 mM or 5 mM. Peptide solutions were incubated with the
resin previously conditioned with the same bu¡er, and kept under
gentle agitation. The volume of settled resin corresponded to a
quarter of that of the peptide solution. Experiments were con-
ducted using either equimolar amounts of resin-bound aldehyde
and peptide, or an excess of two equivalents of aldehyde over
peptide, or an excess of 10 equivalents of aldehyde over peptide.
In di¡erent experiments, at di¡erent time points (from 1 to 24 h)
the supernatant was eliminated by ¢ltration, and the resin was
incubated with a washing bu¡er with the same composition and
volume as the loading bu¡er, and washed for 10 min three times.
Elution was accomplished using a solution of 200 mM O-meth-
ylhydroxylamine hydrochloride in H2O/acetonitrile (1:1) unbuf-
fered (pH 2.9). The eluted material was collected by ¢ltration.
Extent of capture was evaluated by analytical RP-HPLC, per-
formed on a Brownlee Lab HPLC system with 214-nm UV de-
tection, using a Macherey-Nagel C18 analytical column 250U2
mm i.d. at a £ow rate of 0.15 ml/min and linear gradients of
solvent B in solvent A as indicated in the ¢gure legends. Solvent
A = 0.1% TFA in water; solvent B = 0.1% TFA in 90% acetoni-
trile and 9.9% water.
For recombinant Rantes 10^68, the inclusion body fraction
recovered from a 1 liter induction was suspended in 10 ml of
6 M guanidinium chloride, 0.1 M MES, 10 mM TCEP. The
fraction not solubilized was discarded, and the solution added
to 1 ml of dextran resin slurry, previously conditioned with the
same bu¡er. After 12 h capture the resin was washed with 10 ml
bu¡er three times for 10 min, and the peptide eluted with 2 ml of
a water solution of 400 mM O-methylhydroxylamine hydrochlor-
ide and 10 mM TCEP. The recovered quantity was evaluated by
analytical RP-HPLC using as standard Rantes and correcting for
the change in extinction coe⁄cient.
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